Cannon Global Investment Management »

Theravance Biopharma shares owned by Cannon Global Investment Management

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Cannon Global Investment Management from 13F filings

Historical chart of Cannon Global Investment Management investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by Cannon Global Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by Cannon Global Investment Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $260k 16k 16.23
2022-09-30 $659k 65k 10.14